-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KXFUsDqpmL/QomCt6Rzoesgjyt249vgT1I0pvUMJKi/gXQ5MHsHXf5Nm32iC40Ld 4XruAFYtFJLAFR/gTKDXrg== 0001144204-10-022151.txt : 20100611 0001144204-10-022151.hdr.sgml : 20100611 20100426162334 ACCESSION NUMBER: 0001144204-10-022151 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 9920 BELWARD CAMPUS DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 CORRESP 1 filename1.htm Unassociated Document
NOVAVAX, INC.
9920 Belward Campus Drive
Rockville, Maryland 20850
(240) 268-2000
 
 
 
April 26, 2010
 
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: 
Jeffrey Riedler
  
 
Laura Crotty
  
 
 
Re:
Novavax, Inc. Registration Statement
   
on Form S-3 (File No. 333-165496)
 
 
We respectfully request that the Commission, acting pursuant to Section 8(a) of the Securities Act of 1933, as amended, and pursuant to Rule 461(a) promulgated thereunder, enter an appropriate order declaring the above-captioned Registration Statement on Form S-3 effective as of 4:00 p.m., April 27, 2010, or as soon thereafter as practicable.
 
In connection with that request the Company acknowledges: (i) that should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert the staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
 
Please direct any questions regarding the Registration Statement or this request to Jennifer L. Miller of Ballard Spahr LLP at (215) 864-8619.
     
    Sincerely,  
       
 
 
 /s/ Frederick W. Driscoll  
    Frederick W. Driscoll  
    Vice-President, Chief Financial Officer  
    and Treasurer  
 
 -----END PRIVACY-ENHANCED MESSAGE-----